Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$539M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$365M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$361M |
| 4 |
Charter Communications
CHTR
|
+$349M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.31B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$283M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$257M |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$230M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.94% |
| 2 | Healthcare | 5.53% |
| 3 | Financials | 5.03% |
| 4 | Consumer Discretionary | 4.6% |
| 5 | Industrials | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
3726
CALL
DELISTED
Cymabay Therapeutics
CBAY
| $158K | ﹤0.01% |
+45,000
| New | +$162K |
|
|
CBAY
3727
PUT
DELISTED
Cymabay Therapeutics
CBAY
| $158K | ﹤0.01% |
+45,000
| New | +$162K |
|
|
CIR
3728
DELISTED
CIRCOR International, Inc
CIR
| $158K | ﹤0.01% |
9,607
+790
| +9% | +$13.1K |
|
3729
BlackRock Debt Strategies Fund
DSU
$591M
| $157K | ﹤0.01% |
17,633
-1,916
| -10% | -$18.2K |
|
3730
Enviri
NVRI
$624M
| $157K | ﹤0.01% |
41,953
+2,069
| +5% | +$11.5K |
|
3731
Riskified
RSKD
$701M
| $157K | ﹤0.01% |
39,653
+28,595
| +259% | +$134K |
|
3732
ProShares UltraPro QQQ
TQQQ
$31.4B
| $157K | ﹤0.01% |
16,242
-19,002
| -54% | -$277K |
|
|
VMEO
3733
DELISTED
Vimeo
VMEO
| $157K | ﹤0.01% |
39,363
-11,528
| -23% | -$68.2K |
|
3734
Verra Mobility
VRRM
$781M
| $157K | ﹤0.01% |
10,214
-8,023
| -44% | -$130K |
|
3735
iShares US Oil Equipment & Services ETF
IEZ
$353M
| $156K | ﹤0.01% |
10,807
-2,874
| -21% | -$45K |
|
3736
Pacific Biosciences
PACB
$460M
| $155K | ﹤0.01% |
26,755
-18,154
| -40% | -$104K |
|
3737
Relmada Therapeutics
RLMD
$562M
| $155K | ﹤0.01% |
4,182
-58,519
| -93% | -$1.62M |
|
|
AFAR
3738
DELISTED
Aura FAT Projects Acquisition Corp Class A Ordinary Shares
AFAR
| $155K | ﹤0.01% |
+15,400
| New | +$153K |
|
3739
Ecovyst
ECVT
$1.32B
| $154K | ﹤0.01% |
18,181
+375
| +2% | +$3.56K |
|
3740
Lineage Cell Therapeutics
LCTX
$277M
| $154K | ﹤0.01% |
135,981
+131,050
| +2,658% | +$192K |
|
3741
MGE Energy Inc
MGEE
$3B
| $154K | ﹤0.01% |
2,349
-1,211
| -34% | -$94.9K |
|
3742
Surgery Partners
SGRY
$2.08B
| $154K | ﹤0.01% |
6,577
-481
| -7% | -$15.4K |
|
|
FBMS
3743
DELISTED
The First Bancshares, Inc.
FBMS
| $154K | ﹤0.01% |
5,177
-1,177
| -19% | -$35.2K |
|
|
APXI
3744
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
| $154K | ﹤0.01% |
+15,164
| New | +$153K |
|
3745
APi Group
APG
$17B
| $153K | ﹤0.01% |
17,256
-18,386
| -52% | -$196K |
|
3746
Privia Health
PRVA
$3.01B
| $153K | ﹤0.01% |
4,500
-1,760
| -28% | -$65.1K |
|
3747
SSR Mining
SSRM
$5.54B
| $153K | ﹤0.01% |
10,322
-5,131
| -33% | -$77.3K |
|
|
AXNX
3748
DELISTED
Axonics, Inc. Common Stock
AXNX
| $153K | ﹤0.01% |
2,179
-2,224
| -51% | -$153K |
|
|
CIXX
3749
DELISTED
CI Financial Corp.
CIXX
| $153K | ﹤0.01% |
15,882
+2,996
| +23% | +$33.2K |
|
|
ETWO
3750
DELISTED
E2open Parent Holdings
ETWO
| $152K | ﹤0.01% |
24,945
-10,406
| -29% | -$72.9K |
|
Similar funds
Citigroup's Q3 2022 Portfolio in Review
As of Q3 2022, Citigroup held 6,714 positions worth $140B, up 4% from $134B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup deployed $13.5B of net new capital in Q3 2022, opening 321 new positions and adding to 2,151 existing holdings. Its largest new stake was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.31B trimmed.
- Citigroup's largest Q3 2022 buy was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
- Citigroup added most to Lowe's Companies in Q3 2022, an estimated $539M increase.
- Citigroup's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.31B.
- Citigroup fully exited GCP Applied Technologies Inc. in Q3 2022, selling an estimated $18.7M.
- Citigroup's ten largest holdings make up 30% of its $140B portfolio in Q3 2022.
- Citigroup opened 321 new positions and closed 759 in Q3 2022.
- Citigroup's portfolio value rose 4% quarter-over-quarter to $140B.
Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.